Annual Drug Patent Expirations for BREZTRI+AEROSPHERE
Breztri Aerosphere is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
This drug has one hundred and seventy-three patent family members in thirty-three countries.
The generic ingredient in BREZTRI AEROSPHERE is budesonide; formoterol fumarate; glycopyrrolate. One supplier is listed for this compound. Additional details are available on the budesonide; formoterol fumarate; glycopyrrolate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
